Predictors of all-cause 1-year mortality in implantable cardioverter defibrillator patients with chronic Chagas' cardiomyopathy

PACE - Pacing and Clinical Electrophysiology

Volumn 34, Issue 9, 2011, Pages 1063-1069

  Toro, Darío Di ^a   Muratore, Claudio ^b   Aguinaga, Luis ^c   Batista, Luiz ^d   Malan, Antonio ^e   Greco, Oswaldo ^f   Benchetrit, Chamia ^g   Duque, Mauricio ^h   Baranchuk, Adrian ⁱ   Maloney, Jennifer ^j  

^a HOSPITAL GENERAL DE AGUDOS DR COSME ARGERICH   (Argentina)

^b HOSPITAL JUAN A FERNÁNDEZ   (Argentina)

^c Centro Privado de Cardiologia   (Argentina)

^d Centro Medico Medvitta Ltda   (Brazil)

^e Ritmovida ^*  (Brazil)

^f I de Molestias Cardiovasculares   (Brazil)

^g HOSPITAL UNIVERSITARIO DE CARACAS   (Venezuela)

^h Clinica Medellin   (Colombia)

ⁱ QUEEN S UNIVERSITY   (Canada)

^j MEDTRONIC INC   (United States)

more..

Author keywords

Chagas' cardiomyopathy; implantable cardioverter defibrillator; mortality

Indexed keywords

AMIODARONE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SPIRONOLACTONE;

ADULT; ARTICLE; CHAGAS DISEASE; DEFIBRILLATOR; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; RISK FACTOR; SINUS RHYTHM; SUDDEN DEATH;

AGED; ATRIAL FIBRILLATION; CHAGAS CARDIOMYOPATHY; CHRONIC DISEASE; COHORT STUDIES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LATIN AMERICA; MALE; MIDDLE AGED; PROGNOSIS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 80052549111     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2011.03108.x     Document Type: Article

References (26)

1. World Health Organization. Control of Chagas' disease. Report of a WHO Expert Committee. Technical Report Series 811, Geneva, 1991.
2. Dias E, Laranja FS, Miranda A, Nobrega G,. Chagas' disease: A clinical, epidemiologic and pathologic study. Circulation 1956; 14: 1035-1060.
3. Mota EA, Guimaraes AC, Santana OO, Sherlock I, Hoff R, Weller TH,. A nine year prospective study of Chagas' disease in a defined rural population in northeast Brazil. Am J Trop Med Hyg 1990; 42: 429-440. (Pubitemid 20168764)
4. Aras R, de Matta JA, Mota G, Gomes I, Melo A,. Cerebral infarction in autopsies of chagasic patients with heart failure. Arq Bras Cardiol 2003; 8: 411-413.
5. Rassi A Jr, Rassi SG, Rassi A,. Sudden death in Chagas' disease. Arq Bras Cardiol 2001; 76: 75-96.
6. The Antiarrhythmics versus Implantable Defibrillator (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576-1583.
7. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, et al,. Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000; 101: 1297-1303.
8. Kuck KH, Cappato R, Siebels J, Ruppel R,. Randomized comparison of antiarrhythmia drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation 2000; 102: 748-754. (Pubitemid 30648765)
9. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al,. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883. (Pubitemid 34984635)
10. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, et al,. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237. (Pubitemid 40110811)
11. Muratore C, Rabinovich R, Iglesias R, Gonzalez M, Darú V, Liprandi S,. Implantable cardioverter defibrillators in patients with chagas disease: are they different from patients with coronary disease? Pacing Clin Electrophysiol 1997; 20: 194-197. (Pubitemid 27053859)
12. Cardinalli-Neto A, Greco O, Bestetti R,. Automatic implantable cardioverter-defibrillators in chagas heart disease patients with malignant ventricular arrhythmias. Pacing Clin Electrophysiol 2006; 29: 467-470.
13. Muratore CA, Batista Sa LA, Chiale PA, Eloy R, Tentori MC, Escudero J, Lima AM, et al,. Implantable cardioverter defibrillators and Chagas' disease: Results of the ICD Registry Latin America. Europace 2009; 11: 164-168.
14. Cardinalli-Neto A, Bestetti R, Cordeiro J, Rodrigues V,. Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy. J Cardiovasc Electrophysiol 2007; 18: 1236-1240. (Pubitemid 350115777)
15. Lee DS, Tu JV, Austin PC, Dorian P, Yee R, Chong A, Alter DA, et al,. Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J Am Coll Cardiol 2007; 49: 2408-2415. (Pubitemid 46962260)
16. Tandri H, Griffith LS, Tang T, Nasir K, Zardkoohi O, Reddy CV, Capps M, et al,. Clinical course and long-term follow-up of patients receiving implantable cardioverter-defibrillators. Heart Rhythm 2006; 3: 762-768. (Pubitemid 43960547)
17. Stein KM, Mittal S, Gilliam FR, Gilligan DM, Zhong Q, Kraus SM, Meyer TE, et al,. Predictors of early mortality in implantable cardioverter-defibrillator recipients. Europace 2009; 11: 734-740.
18. Parkash R, Stevenson WG, Epstein LM, Maisel WH,. Predicting early mortality after implantable defibrillator implantation: A clinical risk score for optimal patient selection. Am Heart J 2006; 151: 397-403. (Pubitemid 43144742)
19. Theodoropoulos TA, Bestetti RB, Otaviano AP, Cordeiro JA, Rodrigues VC, Silva AC., Predictors of all-cause mortality in chronic Chagas' heart disease in the current era of heart failure therapy. Int J Cardiol 2008; 128: 22-29.
20. Mady C, Cardoso RH, Barretto AC, da Luz PL, Bellotti G, Pileggi F,. Survival and predictors of survival in patients with congestive heart failure due to Chagas' cardiomyopathy. Circulation 1994; 90: 3098-30102.
21. Rabinovich R, Muratore C, Iglesias R, Gonzalez M, Daru V, Valentino M, Luceri R,. Time to first shock in implantable cardioverter defibrillator (ICD) patients with Chagas cardiomyopathy. Pacing Clin Electrophysiol 1999; 22: 202-205. (Pubitemid 29066560)
22. Deneke T, Lawo T, Gerritse B, Lemke B,. European GEM DR Trade Mark Investigators. Mortality of patients with implanted cardioverter/defibrillators in relation to episodes of atrial fibrillation. Europace 2004; 6: 151-158. (Pubitemid 38950184)
23. Rassi A Jr, Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG, Rassi GG, et al,. Development and validation of a risk score for predicting death in Chagas' heart disease. N Engl J Med 2006; 355: 799-808. (Pubitemid 44285585)
24. Dubner S, Valero E, Pesce R, Zuelgaray JG, Mateos JC, Filho SG, Reyes W, et al,. A Latin American registry of implantable cardioverter defibrillators: The ICD-LABOR study. Ann Noninvasive Electrocardiol 2005; 10: 420-428. (Pubitemid 43942701)
25. Muratore C, Baranchuk A., Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathy Vasc. Health Risk Manag 2010; 6: 593-601.
26. Botoni FA, Poole-Wilson PA, Ribeiro AL, et al,. A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy. Am Heart J 2007; 153: 544-548S.